Nanomaterials for Applications in Wastewater Treatment, Biomedical Separation, Sepsis Treatment, and Fuel Cells

USD 250

* Required Fields

USD 250


Be the first to review this product

This issue of Nanotech TOE focuses on using nanoparticles for sepsis and pulmonary arterial hypertension. In addition, a graphene-based membrane for biomedical applications, a novel method for wastewater treatment, a graphene-based Membrane for dialysis, and cost-efficient catalysts for fuel cells are described.

The Nanotech TechVision Opportunity Engine (TOE) provides intelligence on technologies, products, processes, applications, and strategic insights on nanotechnology-related innovations and their impact across various industries. Technology focus areas include nanomaterials, nanocoatings, nanohealthcare, nanomedicine, and nanomanufacturing.

The Chemicals and Advanced Materials cluster tracks research & innovation trends and developments across specialty chemicals, plastics, polymers, chemicals, bio-chemicals, metals, coatings, thin films, surface treatments, composites, alloys, oil and gas, fuel additives, fibers and several other related technologies and its impact and application across industries.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Nanotechnology, wastewater management, catalyst, graphene, water filtration, anti-cancer therapy, fuel cells, dialysis, membrane

Table of Contents

Nanomaterials for Applications in Wastewater Treatment, Biomedical Separation, Sepsis Treatment, and Fuel CellsRecent Innovations Related to NanotechnologyGraphene-based Membrane for Biomedical ApplicationsPhotocatalytic Nanocomposite Fibres for Waste RemovalCeria-zirconia Nanoparticles for Sepsis TreatmentRuthenium-based Catalyst for Cost-efficient Fuel CellsNanoparticles for Drug Delivery in Pulmonary Arterial Hypertension Treatment Key ContactsKey Contacts




Related Subscription

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.